🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Paul J. Chiao

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0001-7003-6605

Also affiliated with The University of Texas Health Science Center at Houston

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 9 papers. Top paper: “CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent regulatory loop”.

CES2 sustains HNF4α expression to promote pancreatic adenocarcinoma progression through an epoxide hydrolase-dependent regulatory loop

Molecular Metabolism(2021)10.1016/j.molmet.2021.101426

N/A

1.0DataRank · unranked

20 citations

Michela Capello, Mayrim V. Rios Perez, Jody V. Vykoukal, David Roife, Ya’an Kang +17 more

E1A Sensitizes Cells to Tumor Necrosis Factor-induced Apoptosis through Inhibition of IκB Kinases and Nuclear Factor κB Activities

Journal of Biological Chemistry(1999)10.1074/jbc.274.31.21495

N/A

0.694DataRank · unranked

101 citations

Mickey C.-T. Hu, Binhua P. Zhou, Shiaw-Yih Lin, Paul J. Chiao, Ryan H. von Lindern +3 more

CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 Diabetes

JCO Precision Oncology(2020)10.1200/po.19.00330

N/A

0.434DataRank · unranked

17 citations

Johannes F. Fahrmann, Mayrim V. Rios Perez, Jody V. Vykoukal, Ehsan Irajizad, S. C. Tripathi +25 more

Targeting a chemo-induced adaptive signaling circuit confers therapeutic vulnerabilities in pancreatic cancer

Cell Discovery(2024)10.1038/s41421-024-00720-w

N/A

0.312DataRank · unranked

7 citations

Yi Xiao, Jun Yao, Yunhai Li, Wendao Liu, Arseniy E. Yuzhalin +26 more

Data from TrkBT1 Induces Liver Metastasis of Pancreatic Cancer Cells by Sequestering Rho GDP Dissociation Inhibitor and Promoting RhoA Activation

(2023)10.1158/0008-5472.c.6499421.v1

N/A

0DataRank · unranked

0 citations

Zhe Chang, Lucia J. Chiao, Ya’an Kang, Qianghua Xia, Cihui Zhu +4 more

Data from Anti-VEGF Treatment–Resistant Pancreatic Cancers Secrete Proinflammatory Factors That Contribute to Malignant Progression by Inducing an EMT Cell Phenotype

(2023)10.1158/1078-0432.c.6519875.v1

N/A

0DataRank · unranked

0 citations

Tania Moccia, Cihui Zhu, Genni Paradiso, Alfredo Budillon, Paul J. Chiao +3 more

Data from Anti-VEGF Treatment–Resistant Pancreatic Cancers Secrete Proinflammatory Factors That Contribute to Malignant Progression by Inducing an EMT Cell Phenotype

(2023)10.1158/1078-0432.c.6519875

N/A

0DataRank · unranked

0 citations

Tania Moccia, Cihui Zhu, Genni Paradiso, Alfredo Budillon, Paul J. Chiao +3 more

Nardilysin-regulated scission mechanism activates polo-like kinase 3 to suppress the development of pancreatic cancer

Nature Communications(2024)10.1038/s41467-024-47242-3

N/A

0DataRank · unranked

3 citations

Jianhua Ling, Ching-Fei Li, Chi-Lin Tsai, Wenjuan Yin, Junwei Hou +26 more

3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinoma

Journal of Clinical Investigation(2022)10.1172/jci151604

N/A

0DataRank · unranked

34 citations

Jenying Deng, Jianhua Ling, Xinqun Li, Yi‐Ju Chiang, Eugene J. Koay +19 more